Status:
COMPLETED
New IR Biomarkers (Myokines) in Colombian People
Lead Sponsor:
University of Los Andes, Columbia
Collaborating Sponsors:
The Administrative Department of Science, Technology and Innovation, Colciencias
Universidad Militar Nueva Granada
Conditions:
Insulin Resistance
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35-65 years
Brief Summary
Around the world, the prevalence of type 2 diabetes mellitus (T2DM) has been increasing since the last two decades, with approximately 347 million patients with diabetes by 2013 according to the World...
Detailed Description
The objectives of the project are: 1) To identify, within a group of 3 potential new biomarkers of insulin resistance, those that are significantly associated with the presence of this phenomenon in o...
Eligibility Criteria
Inclusion
- Age between 35-65 years
- Diligence of informed consent
- Absence of acute illness
- Body mass index less or greater than 25 kg/m2, and presence or absence of a previous diagnosis of diabetes according to the criteria previously stated.
Exclusion
- Current therapy with insulin
- Type 1 diabetes
- Oral or injectable anticoagulation
- Previous diagnosis of insulinoma, insulinomatosis, glucagonoma, or other neoplastic disorders of the endocrine pancreas.
- Pregnant women
- BMI \<18.5 kg / m2
Key Trial Info
Start Date :
August 26 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2016
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT03244449
Start Date
August 26 2014
End Date
December 16 2016
Last Update
August 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.